Introduction
Mood disorders are associated with cognitive abnormalities, especially in the perception and consolidation of emotional stimuli (Leppänen, 2006) . In addition, depressed individuals exhibit impaired social functioning (Cooley and Nowicki, 1989 ) mainly due to the accompanying cognitive deficits, which handicap interpersonal processes (Hale, 1998 ; Pine et al., 2004) . According to the dominant cognitive paradigm for depression, Beck's model, maladaptive cognition is implicated in both the aetiology and maintenance of the depressive process (Beck et al., 1979) . Depressed individuals have the tendency to appraise themselves, others and their daily events with negative expectancies (Beck et al., 1979 ; Lewinsohn et al., 1981) , and to selectively recall negative information or exhibit an attentional bias towards negative emotional cues, a finding known as abnormal or negative emotional memory bias of depression (Bradley et al., 1995 ; Gotlib et al., 2004 ; Leppänen, 2006 ; Surguladze et al., 2004 ; Zakzanis et al., 1998) . Additionally, depressive patients tend to attribute negative events (Sweeney et al., 1986) and negative self-evaluations to themselves (Giesler et al., 1996) . Depressive individuals specifically endorse and recall less positive information and organize positive selfrelevant information with less interconnectedness than anxious individuals and controls, suggesting that they have an interconnected negative selfrepresentational system and lack a well-organized positive template of self (Dozois and Dobson, 2001) .
Thus, dysfunctional interpersonal interactions, as a consequence of negative bias, may sustain depression symptoms (Coyne et al., 1991) . Depressive persons elicit support behaviour, intermixed with rejection attitudes, from persons in their general surroundings, and continuously increase their support-seeking behaviour until these persons eventually withdraw. Interpersonal interactions of depressive persons, such as giving or receiving social support, are heavily impaired (McNaughton et al., 1992) , and their readiness to perceive and attend to negative aspects in interpersonal relationships may lead to decreased social support (Gotlib and Hammen, 1992) . Finally, this maladaptive process contributes decisively to increased risk of depression chronicity (Brown et al., 1994) . In addition, abnormalities in the processing of emotional information heighten the risk of the development of mood disorders (Leppänen, 2006) . Therefore, understanding the negative aspects of the cognitive processes that lead to maladaptive interpersonal interactions in depression and improvement of these cognitive difficulties may help patients.
Facial expressions are stimuli with a high arousal effect and the recognition of emotional facial expressions is a perceptual-interpretive process that is highly developed in human and non-human primates, reflecting its social and behavioural importance (Rubinow and Post, 1992) . Facial expressions of basic emotions are archetypal social cues that are instantly recognizable and modulate interpersonal behaviour (McArthur and Baron, 1983) . Cross-cultural studies indicate that the recognition and expression of basic emotions in facial expressions show universal similarity (Ekman, 1993) . Therefore, facial expressions are useful tools to employ in the study of cognitive processes in interpersonal interactions.
In the present study, using an emotional facial recognition test, which applies the signal detection and discrimination paradigm, we investigated the memory for facial identity in elderly depressive patients before and after the treatment with a selective serotonin reuptake inhibitor (SSRI), escitalopram. Since depression is a common disorder in the elderly greatly disabling them in their individual and social behaviour, we hypothesize that antidepressive treatment with escitalopram may improve the cognitive parameters contributing to the recovery process. The main hypotheses of this investigation were : (1) Depressive patients have impaired identity recognition memory compared to healthy age-matched control subjects. (2) Elderly control subjects show the well-documented emotional expression bias that they better recognize happy identities. 
Method

Study design
The present study was a 4-wk, single-centre, openlabel trial to assess the effects of treatment with escitalopram on affective and cognitive symptoms, and on memory for facial identity in elderly depressed patients compared to healthy age-matched controls. The protocol was approved by the local Ethics Committee and conformed to the provisions of the Declaration of Helsinki. Written informed consent was obtained, and full and adequate oral and written information about the objectives of the study, possible therapeutical advantages and side-effects were given to the participants.
The inclusion criteria were a confirmed diagnosis of a current depressive episode according to ICD-10 criteria (major depression, first episode), permanent medical or social care available during the study, written informed consent and age >65 years. The exclusion criteria included known sensitivity to escitalopram, evidence of severe and/or chronic renal, hepatic, cardiovascular, pulmonary or gastrointestinal impairment or cancer, other psychiatric disorders or dementia, drug abuse, concomitant medication with clonidine or beta-blockers, and participation in any other drug trial. Subjects were free to withdraw their informed consent at any time, without prejudice to further treatment.
Patient data was collected during three visits. Visit 1 : during the run-in period for baseline assessments to check inclusion and exclusion criteria ; visit 2, 1 d prior to commencing study drug, and visit 3 at the end of the fourth week of treatment. The facial picture recognition test and the additional psychometric test battery were performed twice during visits 2 and 3 in depressed patients. Since all patients with depression were in-patients, they all underwent a routine physical and laboratory examination and electrocardiogram during the baseline period. Healthy elderly controls were assessed only during visits 1 and 2, and the facial picture recognition test and the additional psychometric tests were performed once during visit 2.
Patients and control subjects
All patients with depression were in-patients hospitalized on the gerontopsychiatric ward. Twenty-two patients were included in the study. Four patients dropped out during the course of the study because of withdrawal of informed consent, evidence of psychotic symptoms or acute infection. Thus, a total of 18 patients finished the 4-wk treatment period and could be evaluated : 14 women and 4 men (Table 1) , mean age (¡S.E.M.) 76.2¡1.8 yr. Additionally, 22 elderly controls, 16 women and 6 men, were included in the study (mean age 76.9¡1.8 yr), who were recruited by local advertisement and from retirement homes. Only healthy elderly participants were included in the study without acute or chronic severe diseases which was confirmed by physical examination and a report from their medical caregivers.
Medication
Concomitant medication was allowed with the exception of clonidine and beta-blockers. Concomitant psychiatric medication, especially benzodiazepines and hypnotics, were only allowed during the initial acute phase of the depression starting after visit 2 assessments. Then concomitant psychiatric medication was withdrawn during the next 2 wk of treatment. Escitalopram was chosen as the antidepressive medication since the R-enantiomer present in citalopram has been suggested to reduce the efficacy of Senantiomer (escitalopram) which is mainly responsible for the serotonin reuptake inhibitory activity of the compound (Sánchez et al., 2004) . The starting dose was 5 mg, which was increased in 5-mg steps every 1-2 wk, based on the clinical judgement of the investigators. The maximum allowed dose of escitalopram was 20 mg.
Experimental stimuli and facial picture recognition test
For testing the memory for facial identity picture photographs of male faces with happy (positive) or angry (negative) expressions were presented on a computer screen approximately 60 cm in front of the seated participants. The two emotional expressions ' happy' and 'angry ' were chosen because of their high social relevance in approach and avoidance dimensions. The generation of test material is described in detail in a previous study (Savaskan et al., 2007) .
Participants were asked to look carefully at the presented faces, and especially observe their characteristics and emotional expressions, in order to recognize them later in the second part of the test. For the encoding task, participants saw 30 randomly assorted faces with angry or happy expressions of 30 different subjects. Each picture was presented for 10 s, and there was a 3-s interval between each picture, appearing as a white screen. After a 10-min retention interval, 60 faces were presented to the participants in the recognition task, all with neutral expression. Thirty pictures included in the recognition task were the neutral faces of 30 individuals presented during the encoding task and the remaining 30 pictures showed new faces. After each picture participants were asked to identify each face as old or new.
Then the sensitivity index d' from signal detection theory was calculated to get a bias-free measure of memory strength for identity recognition (Wickens, 2002) . For identity recognition an overall hit and falsealarm rate and two expression-specific hit rates were calculated for each subject. These values were used to calculate d' as z(hit rate) -z(false alarm rate) for the overall and the two expression-specific recognition performances for each subject. To compare memory performances between and within the different groups several ANOVAs were conducted with d' as the dependent variable. As escitalopram was expected to improve cognitive function and memory, hypothesis 5 was tested with a-priori constructed, one-sided contrast based on t tests. A x 2 test was used to explore the memory bias for faces acquired with happy expression. Effects of subject education were assessed by Student's t test and Mann-Whitney U test again with d' as the dependent variable.
Psychometric test battery
Geriatric Depression Scale (GDS)
The GDS was originally devised by gathering 100 questions relating to depression in older people, and then selecting the 30 that correlated best with the total score, and has shown high sensitivity and specificity (Yesavage et al., 1983) . Each question has a yes/no answer, with the scoring dependent on the answer given. Scores >6 indicate a depressive disorder, and only subjects with scores >6 were included as depressive patients in the study. The mean GDS baseline scores of the participants was 9.4¡0.4 for elderly depressed patients and 1.2¡0.3 for age-matched controls (Table 1) .
Mini-Mental State Examination (MMSE)
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place, registration of three words, attention and calculation, recall of three words, language and visual construction. Scores <26 indicate cognitive disturbances and need further evaluation to exclude organic or non-organic cognitive disorders. The MMSE was performed twice in depressed patients at baseline and after 4-wk treatment period to assess cognitive improvement. Since all patients were in-patients, those patients with a MMSE score <26 underwent a routine dementia screening procedure including neuroimaging and a Consortium to Establish a Registry for Alzheimer's Disease (CERAD) test battery to exclude dementia. The mean MMSE baseline scores of the participants were 26.9¡0.5 for elderly depressed patients and 29¡0.2 for age-matched controls (Table 1) .
Results
Demographic data and the results of GDS and MMSE assessments are summarized in Table 1 . Eighteen elderly depressed patients (excluding four drop-outs) and 22 age-matched controls were evaluated. No severe adverse events were observed during the therapy with escitalopram in depressed patients. Three patients complained of mild adverse events such as gastrointestinal discomfort and nausea in the first week of the antidepressive therapy. Two patients had urinary infections during the treatment period and were treated with norfloxacin for 5 d. However, none of these two patients had antibiotic therapy during the visit 3 assessments. The mean dose of escitalopram at the end of the 4-wk treatment period was 16.1¡0.8 mg.
ANOVA was performed with the between-subject factor 'group' and the within-subject factor ' emotional expression ' -the latter based on d' values calculated separately for acquired faces with happy and angry expression -and revealed that depressive patients have lower identity recognition memory performance than healthy age-matched control subjects (hypothesis 1) (F 1,38 =4.6, p=0.038 ; see also Figure 1 ). When examining this difference in more detail it appeared that this difference was mainly due to memory performance of identities acquired with happy facial expressions (p=0.018, see Figure 1 ).
Subjects in the control group had a better recognition of identities with a happy facial expression (hypothesis 2) (p=0.046, see Figure 1 ). This, however, was not the case for depressed patients, neither before, nor after treatment with escitalopram (hypothesis 3). There were seven out of 22 control subjects who had a better identity recognition for faces acquired with angry expression and 15 who had a better or equal identity recognition for faces acquired with happy expression. However, 11 out of 18 depressed patients showed better identity recognition for faces acquired with angry expression and seven did not show this behaviour. An a-priori constructed one-sided x 2 test was based on this distribution and revealed statistical significance (p=0.03). Thus, with respect to the well-established identity recognition memory bias, depressed patients failed to respond to happy-face stimuli.
Within the treatment group GDS scores improved significantly from baseline (p<0.0001) after the 4-wk treatment period (hypothesis 4). Group mean scores were 9.4 (¡0.4) before and 4.7 (¡0.6) after treatment. MMSE values also improved significantly (p=0.023) after treatment from 26.8 (¡0.5) to 27.9 (¡0.4).
Treatment of depressive patients with escitalopram did not improve identity recognition memory for faces acquired with happy expression. However, escitalopram improved identity recognition memory for faces acquired with angry expression. Before treatment the mean d' was 0.46 (¡0.13), and after treatment it was 0.62 (0.1, p=0.05) (hypothesis 5). Individual improvement (change in GDS or MMSE scores) after treatment with escitalopram did not significantly correlate with changes in identity recognition performance (hypothesis 6).
Discussion
The present study shows significant effects of antidepressive therapy on affective and cognitive Figure 1 . Identity recognition memory performance of normal control subjects (Con) and depressed patients (Dep) prior to treatment with escitalopram. Overall, the memory performance of control subjects is better than that of depressed patients (p=0.038). This difference is pronounced when only faces with happy expression are considered (p=0.018). Control age-matched subjects have better recognition memory performance for identities with happy facial expression vs. angry facial expression. However, this was not the case for depressed patients.
parameters in elderly depressed patients as shown by GDS and MMSE results. In addition, antidepressive therapy was able to improve memory for facial identity for negative stimuli. The main findings at baseline were a general reduction in memory performance in elderly depressed patients and a bias towards positive (happy) facial identities in healthy elderly controls. The latter is in accordance with our previous findings in healthy elderly subjects (Savaskan et al., 2007) . Happy faces were found to be better recognized in all observed age groups (young adults : 20-40 yr ; elderly adults : 60-80 yr ; and very old adults : >80 yr) than angry faces (Savaskan et al., 2007) . Although there was a continuous overall decrease in recognition of both happy and angry faces with advanced age in those healthy individuals, the effect favouring happy facial expressions was found to be stable in old and very old adults. Decreased facial identity recognition was suggested to underlie difficulties in emotion processing in the elderly, and to contribute to behavioural and social difficulties in their daily life.
Although there was a positive bias towards happy facial identities in age-matched control subjects, this was not observed in patients with depression prior to and after the treatment period in the present study. Thus, 61.1 % of patients with depression showed a better identity recognition for faces with angry expression, whereas only 31.8 % of control subjects showed this behaviour. This is in accordance with previous studies suggesting a negative cognitive bias in depressed patients : a review summarizing the results of studies investigating emotional information processing in mood disorders has shown this negative bias for young depressed patients (Leppänen, 2006) . In addition, young depressed patients were shown to have a general impairment in displaying emotional facial expressions (Wexler et al., 1994) , and were generally impaired in the recognition of affect in the facial expressions (Rubinow and Post, 1992) . Their interpersonal difficulties have been suggested to be strongly linked to the fact that they exhibit difficulty in accurately decoding facial expressions of emotions as well as in their behavioural and emotional responses to these expressions (Persad and Polivy, 1993) . Young depressed patients, relative to the non-depressed controls, were found to make more errors in recognizing facial expressions and reported more tensing, higher fear and depression reactions, and feeling less comfortable with their own emotional reactions.
In general, emotion perception is disproportionately negatively affected relative to other cognitive functions in depressed patients (Langenecker et al., 2005) , and depressed patients show subtle impairments in discrimination accuracy and predominant bias away from the identification of happy expressions (Surguladze et al., 2004) . On the other hand, clinically stabilized depressed in-patients were significantly slower in responding to positive faces than normal subjects, whereas they did not show performance differences in the detection of negative faces, suggesting that depressive mood may also be associated with a reduced spatial attention to positive facial expression (Suslow et al., 2001) . Moreover, some of these abnormalities in the processing of emotional information persisted after symptom remission (Leppänen, 2006) . This may explain why patients failed to improve their recognition of happy facial expressions after the treatment period in the present study. Another factor may be that depressive patients require significantly greater intensity of emotion than control subjects to correctly identify happy expressions (Joormann and Gotlib, 2006) . Interestingly, poorer memory performance for emotional facial expressions was significantly associated with larger left amygdala volumes in depressed patients taking antidepressant medication (Weniger et al., 2006) .
One limitation of the present study may be the dominance of female subjects in both groups which represents the demographics of the main population in this age group. In a previous study gender effects were reported on memory for facial identity : women were found to identify more male faces correctly than female faces, irrespective of the emotion expressed (Rahman et al., 2004) . Since only pictures of male faces were included in the present study, this effect may not limit study results. Two other studies demonstrated a female advantage across emotions regardless of the sex of the face presented (Campbell et al., 2002 ; Thayer and Jonsen, 2000) whilst one reported that the sex of the subject interacted with the sex of the face (Erwin et al., 1992) . Women were found to be more sensitive to happiness in male faces (Erwin et al., 1992) whereas later data have shown women to be more accurate at identifying male faces regardless of emotion (Rahman et al., 2004) . Nevertheless, our previous data have shown that gender-related differences in facial identity may not have a significant impact in the elderly (Savaskan et al., 2007) .
There was a significant improvement from baseline in GDS and MMSE scores during the 4-wk treatment period in the present study, and escitalopram was well tolerated. Mild adverse events such as gastrointestinal discomfort and nausea were observed in three of the 22 patients within the first week of treatment. The effects of citalopram on cognitive processing of emotional cues have been studied previously in healthy young volunteers (Harmer et al., 2003 (Harmer et al., , 2004 . Volunteers receiving a single dose of citalopram were found to detect a higher number of facial expressions of fear and happiness, with reduced response times, relative to those given a placebo (Harmer et al., 2003) . Citalopram also reduced the identification of the negative facial expressions of anger and fear after 7 d treatment, and abolished the increased startle response found in the context of negative affective images (Harmer et al., 2004) . In addition, it increased the relative recall of positive (vs. negative) emotional material. Thus, volunteers receiving citalopram for 7 d showed decreased amygdala responses to masked presentations of threat compared to placebo, and citalopram was able to reduce responses within the hippocampus and medial prefrontal cortex specifically during the fear-relevant stimuli (Harmer et al., 2006) . Interestingly, there was no effect of citalopram on the neural or behavioural response to happy facial expressions in the latter study. These results suggest a direct effect of serotonin potentiation on amygdala response to threat-relevant stimuli in humans. Since elderly depressed patients were investigated, not only age, but also the differential effects of escitalopram therapy on emotional processing of negative or positive stimuli may account for the failure of these patients to show a positive bias after the treatment period in the present study. It has been suggested that antidepressant therapy may not directly affect mood but may initiate a cascade of changes in emotional processing, which ultimately affects low mood and anxiety through changes in social reinforcement and the detection of environmental threat (Harmer et al., 2006) . Elderly subjects have an overall reduction in cognitive performance for identity memory (Savaskan et al., 2007) , and therefore, elderly patients might need a longer treatment period to overcome the memory deficits for emotional stimuli. However, the positive effect of the SSRI on cognitive processing of negative stimuli may provide an additional clue in the treatment of depression.
In conclusion, the present data show that elderly depressed patients have not only affective and overall cognitive symptoms, but also deficits in facial identity recognition memory, especially for identities with happy facial expressions. This may provide a critical performance deficit complicating interpersonal behaviour difficulties in depressed patients. Antidepressant therapy with escitalopram improved mood, overall cognitive performance and the memory for negative facial stimuli, but not for positive stimuli. The SSRI treatment seems to be effective in decreasing the negative bias of depression and may help improve patients' maladaptive social interactions.
